1. Home
  2. CVKD vs MIRA Comparison

CVKD vs MIRA Comparison

Compare CVKD & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • MIRA
  • Stock Information
  • Founded
  • CVKD 2022
  • MIRA 2020
  • Country
  • CVKD United States
  • MIRA United States
  • Employees
  • CVKD N/A
  • MIRA N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVKD Health Care
  • MIRA Health Care
  • Exchange
  • CVKD Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • CVKD 8.2M
  • MIRA 9.4M
  • IPO Year
  • CVKD 2023
  • MIRA 2023
  • Fundamental
  • Price
  • CVKD $0.46
  • MIRA $0.59
  • Analyst Decision
  • CVKD Strong Buy
  • MIRA
  • Analyst Count
  • CVKD 2
  • MIRA 0
  • Target Price
  • CVKD $3.50
  • MIRA N/A
  • AVG Volume (30 Days)
  • CVKD 81.6K
  • MIRA 39.3K
  • Earning Date
  • CVKD 08-12-2024
  • MIRA 05-13-2024
  • Dividend Yield
  • CVKD N/A
  • MIRA N/A
  • EPS Growth
  • CVKD N/A
  • MIRA N/A
  • EPS
  • CVKD N/A
  • MIRA N/A
  • Revenue
  • CVKD N/A
  • MIRA N/A
  • Revenue This Year
  • CVKD N/A
  • MIRA N/A
  • Revenue Next Year
  • CVKD N/A
  • MIRA N/A
  • P/E Ratio
  • CVKD N/A
  • MIRA N/A
  • Revenue Growth
  • CVKD N/A
  • MIRA N/A
  • 52 Week Low
  • CVKD $0.36
  • MIRA $0.51
  • 52 Week High
  • CVKD $2.17
  • MIRA $6.95
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 48.23
  • MIRA 45.02
  • Support Level
  • CVKD $0.43
  • MIRA $0.51
  • Resistance Level
  • CVKD $0.48
  • MIRA $0.62
  • Average True Range (ATR)
  • CVKD 0.03
  • MIRA 0.05
  • MACD
  • CVKD -0.00
  • MIRA 0.00
  • Stochastic Oscillator
  • CVKD 21.49
  • MIRA 54.78

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: